Dermal Toxicity Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Test Type (Skin Irritation Tests, Skin Sensitization Tests), By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests), By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other), By Region, By Competition

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Forecast Period

2024-2028

Market Size (2022)

USD 1.81 Billion

CAGR (2023-2028)

8.17%

Fastest Growing Segment

Cosmetic & Personal Care

Largest Market

North America


Market Overview

Global Dermal Toxicity Testing Market has valued at USD 1.81 Billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 8.17% through 2028. Dermal toxicity testing is a comprehensive process aimed at assessing the adverse effects of substances on human skin. It involves subjecting test substances to various protocols, ranging from traditional animal-based methods to innovative in vitro models that replicate human skin characteristics. The primary goal is to identify any irritations, allergic reactions, sensitizations, or systemic toxicities that might arise from dermal exposure. The field of dermal toxicity testing has witnessed remarkable progress, transitioning from reliance on animal testing to more advanced and humane methods. In vitro models, 3D skin equivalents, and microfluidic platforms are revolutionizing the accuracy and efficiency of testing.

Key Market Drivers

Industry-Specific Demands

Industry-specific demands can play a significant role in influencing the growth of the global dermal toxicity testing market. Dermal toxicity testing involves assessing the potential harmful effects of substances on the skin, and it is a crucial aspect of product safety evaluation, especially in industries like cosmetics, pharmaceuticals, chemicals, and consumer goods. Different industries have distinct regulations and guidelines governing product safety and testing. For instance, the cosmetics industry must adhere to regulations set by authorities like the U.S. FDA or the European Medicines Agency (EMA). These regulations often require thorough dermal toxicity testing to ensure the safety of ingredients used in products. As regulatory requirements evolve, industries are compelled to adopt advanced testing methods, driving the growth of the dermal toxicity testing market. The cosmetics industry places high importance on dermal toxicity testing to ensure that skincare products, makeup, and other personal care items do not cause adverse skin reactions. With the rising consumer demand for natural and organic products, the need for thorough testing to verify product safety has grown. This drives the demand for innovative dermal toxicity testing methods that are more accurate, efficient, and reflective of real-world usage. In the pharmaceutical sector, dermal toxicity testing is essential for assessing the safety of transdermal drug delivery systems, such as patches and creams. As pharmaceutical companies develop new drugs and delivery mechanisms, they require advanced testing methodologies that provide detailed insights into how these substances interact with the skin. This drives the adoption of new testing techniques and fuels market growth. Industries dealing with chemicals, including industrial, agricultural, and household chemicals, need to ensure the safety of their products to protect workers and consumers. Dermal toxicity testing is crucial to determine potential risks associated with skin exposure. As awareness of workplace safety and consumer health increases, companies in these sectors are likely to invest in more comprehensive testing methods, contributing to market growth.

Transition to Non-Animal Testing Methods

The transition to non-animal testing methods has a significant impact on the growth of the global dermal toxicity testing market. As concerns about animal welfare, regulatory changes, and technological advancements drive the adoption of alternative testing methods, the market experiences shift that influences its growth trajectory. Many regulatory bodies worldwide are increasingly advocating for and even mandating the use of non-animal testing methods in safety assessments. For instance, the European Union's REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) regulation promotes the use of alternative methods to animal testing for chemical safety evaluations. As regulatory authorities recognize and endorse non-animal methods, companies are motivated to adopt these methods to remain compliant. This leads to market growth as businesses invest in new testing technologies to meet regulatory standards. The use of animals for testing is a contentious ethical issue and can negatively impact a company's reputation. As public awareness of animal welfare grows, consumers and stakeholders may favor companies that employ cruelty-free testing methods. Adopting non-animal testing not only aligns with ethical considerations but also helps companies maintain a positive public image, thus potentially boosting market growth. Non-animal testing methods have evolved significantly over the years. In vitro techniques reconstructed human skin models, and computational modeling have improved in accuracy and reliability, making them viable alternatives to traditional animal testing. As the scientific community develops and validates these methods, industries seeking more predictive and efficient testing are inclined to adopt them, contributing to market expansion. The shift toward non-animal testing methods encourages research and innovation in the field of toxicology. This includes the development of novel techniques, improved models, and more accurate predictions of human responses. Industries that prioritize innovation and stay at the forefront of scientific advancements are likely to invest in these methods, fostering market growth.

Technological Innovations

Technological innovations play a crucial role in influencing the growth of the global dermal toxicity testing market. As advancements in technology offer more accurate, efficient, and cost-effective testing methods, industries and regulatory bodies are increasingly adopting these innovations to ensure product safety. Technological advancements have led to the development of sophisticated in vitro testing methods. These methods use human-derived cells, tissues, and 3D models to simulate skin reactions accurately. In vitro testing offers a more relevant and reliable representation of human responses compared to traditional animal testing, contributing to its adoption by industries seeking accurate toxicity assessments. Microfluidics and organ-on-a-chip technologies enable the creation of miniaturized devices that mimic the structure and function of human organs, including the skin. These models provide a controlled environment to study cellular responses to substances. They offer real-time insights into toxicity and can simulate the dynamics of substances interacting with the skin, aiding in the identification of potential hazards and driving market growth. High-throughput screening technologies allow for the rapid testing of many substances simultaneously. This technology accelerates the screening process, making it feasible to assess multiple compounds for dermal toxicity efficiently. Industries can use HTS to identify potential hazards early in the product development process, reducing costs and time-to-market, which contributes to market expansion. Computational modeling and AI techniques enable the prediction of dermal toxicity based on molecular structures and interactions. These methods use databases of known toxic substances and their effects to predict the potential toxicity of new compounds. The integration of AI into toxicity testing enhances predictive capabilities and reduces the need for extensive lab testing, thus fostering market growth.

Public Awareness and Brand Reputation

Public awareness and brand reputation have a significant influence on the growth of the global dermal toxicity testing market. As consumers become more conscious of product safety and ethical considerations, and as brands strive to maintain positive reputations, the demand for comprehensive dermal toxicity testing increases. In today's socially conscious world, consumers are increasingly concerned about ethical practices, including animal welfare and environmental impact. Brands that prioritize non-animal testing methods and demonstrate a commitment to ethical product development are likely to resonate with these consumers. As public awareness of ethical considerations grows, brands that adopt responsible testing practices can gain a competitive advantage, driving the demand for comprehensive dermal toxicity testing. Public awareness of potential health risks associated with products has led consumers to demand safer and more transparent formulations. Brands that conduct thorough dermal toxicity testing to ensure product safety can build trust with consumers. By addressing consumer safety concerns through rigorous testing and accurate labeling, brands can enhance their reputation and foster customer loyalty.

 

Download Free Sample Report

Key Market Challenges

Validation of Alternative Methods

The validation of alternative methods can pose challenges and potentially hinder the growth of the global dermal toxicity testing market. While alternative methods are sought after due to their ethical considerations and scientific advancements, their validation process can be complex and time-consuming. The validation of alternative methods requires extensive research, data collection, and comparison to established reference methods, often including animal testing benchmarks. This process can be time-consuming and resource-intensive, slowing down the adoption of these methods. As a result, market growth might be hindered, especially in the short term. Regulatory bodies typically require validation data to demonstrate the reliability and predictability of alternative methods. The acceptance of these methods in regulatory frameworks may take time, as agencies need to be convinced of their equivalence to existing methods. This delay can slow down the market growth, as companies hesitate to fully adopt alternative methods until they receive regulatory approval. The validation process aims to establish consistent and reproducible results across different laboratories and testing conditions. Variability in results can arise due to differences in protocols, equipment, or expertise. This lack of consistency can lead to skepticism about the reliability of alternative methods, causing some companies to hesitate in adopting them until these issues are resolved.

Standardization Issues

Without standardized protocols, laboratories might use different procedures, equipment, and conditions for conducting dermal toxicity tests. This can result in inconsistent and variable test results, making it difficult to compare findings between different studies or laboratories. Such inconsistencies can undermine confidence in the reliability of test methods and hinder market growth. Regulatory agencies often require standardized testing protocols to ensure the validity and reproducibility of results. The lack of standardized methods can complicate the process of obtaining regulatory approvals for products, as agencies might be hesitant to accept data generated from non-standardized approaches. In the absence of standardized procedures, different laboratories might produce different results when testing the same substance. This variability can be due to differences in equipment calibration, handling procedures, and data interpretation. Industries might be wary of using non-standardized methods if they fear that results could vary significantly between laboratories. Standardized methods are crucial for validating alternative testing approaches and gaining regulatory acceptance. Without standardized protocols, it becomes challenging to demonstrate the equivalence of alternative methods to established methods. This can slow down the adoption of innovative testing methods and hinder market growth.

Key Market Trends

Advanced In Vitro Models

Advanced in vitro models better replicate human skin physiology, allowing for more accurate predictions of dermal toxicity. These models can mimic skin barrier function, cellular interactions, and complex biological processes, providing more reliable insights into how substances interact with human skin. As accuracy improves, industries can confidently assess potential hazards and make informed decisions about product safety. The use of animals for testing raises ethical concerns, and industries are increasingly turning to non-animal methods. Advanced in vitro models offer an ethical alternative by eliminating the need for animal testing while still providing scientifically meaningful results. Brands that prioritize ethical testing practices can enhance their reputation and appeal to consumers who value cruelty-free products. Regulatory bodies are recognizing the value of advanced in vitro models for safety assessment. As these methods become more validated and established, regulatory acceptance is increasing. Industries can use these methods to fulfill regulatory requirements, which accelerates their adoption and drives market growth. In vitro models offer quicker results compared to animal testing, allowing industries to streamline their testing processes and reduce time-to-market. Additionally, the ability to test multiple substances simultaneously enhances efficiency. While initial setup costs might be involved, the long-term cost-effectiveness of in vitro models can drive their adoption and market growth. Advanced in vitro models can be customized to mimic specific skin types, conditions, and populations. This flexibility enables industries to tailor testing to their products' target audiences, improving the relevance and accuracy of toxicity assessments. This customization can attract industries seeking personalized and precise testing solutions.

High-Throughput Screening

High-throughput screening allows for the simultaneous testing of multiple compounds, accelerating the testing process. This efficiency is particularly valuable in industries with high product turnover rates, as it enables faster decision-making and reduces time-to-market for new products. Traditional toxicity testing methods can be time-consuming and expensive. HTS optimizes resource utilization by testing numerous compounds in a single experiment, leading to cost savings over time. The cost-effectiveness of HTS can drive its adoption, particularly for industries seeking efficient and economical testing solutions. HTS generates a large amount of data quickly, providing comprehensive insights into the potential toxicity of various substances. This data-rich approach enhances the depth of analysis and enables industries to better understand the relationship between chemical structures and toxic effects, ultimately contributing to more informed decision-making. HTS allows industries to identify potential hazards and adverse effects at an early stage of product development. Detecting toxicity at an early phase enables corrective actions to be taken promptly, reducing the likelihood of costly recalls or safety issues after a product has already entered the market. HTS can encompass a wide range of toxicity endpoints, including skin irritation, sensitization, and more complex effects. The ability to assess multiple aspects of dermal toxicity within a single experiment makes HTS a valuable tool for industries seeking comprehensive safety evaluations. The pharmaceutical and cosmetic industries benefit from HTS due to their high demand for safety testing and frequent product releases. For pharmaceuticals, HTS aids in identifying potential lead compounds with minimal toxicity profiles. In cosmetics, HTS helps assess the safety of numerous ingredients in various formulations.

Segmental Insights

Testing Method Type Insights

Based on the Testing Method Type, the In Vitro Testing segment is anticipated to witness substantial market growth throughout the forecast period. This growth can be attributed to multiple factors, such as In vitro models closely mimic human skin in terms of structure and function. This fidelity translates into more accurate predictions of how chemicals interact with human skin, resulting in more reliable toxicity assessments. The adoption of in vitro methods significantly reduces the reliance on traditional animal testing, aligning with ethical considerations and the broader trend toward minimizing animal usage in scientific research. Regulatory agencies worldwide are increasingly acknowledging the value of in vitro testing methods. This recognition provides a strong impetus for their adoption, streamlining approval processes and facilitating market access. In vitro-based testing methods often offer faster results compared to animal testing, allowing for quicker decision-making in product development. Additionally, these methods can reduce costs associated with animal care and maintenance.

End Use Insights

Based on the end-use segment, the Cosmetics and personal care products industry segment has been the dominant force in the market. The industry's commitment to safety is fueling the expansion of the dermal toxicity testing market. Companies that invest in these testing methodologies are contributing to and benefiting from this growth. The industry's drive for innovation is fostering research and development in dermal toxicity testing methods. This collaboration is leading to the evolution of more advanced and accurate testing technologies. Companies that prioritize rigorous dermal toxicity testing can build a strong brand reputation rooted in safety and transparency. This fosters consumer loyalty and trust, essential for sustained market success. Consumer awareness about animal welfare is compelling the cosmetics and personal care industry to reduce or eliminate animal testing. The adoption of non-animal testing methods, such as in vitro models, aligns with ethical considerations while ensuring accurate safety assessments.

 

Download Free Sample Report

Regional Insights

North America, specifically the Dermal Toxicity Testing Market, dominated the market in 2022, primarily due North America, particularly the United States and Canada, boasts robust research infrastructure, including academic institutions, research organizations, and private companies. This facilitates the development and validation of innovative dermal toxicity testing methods, positioning the region at the forefront of technological advancements. The presence of major pharmaceutical and cosmetics industries in North America fuels the demand for thorough dermal toxicity testing. These industries prioritize safety assessments to ensure that their products meet regulatory requirements and consumer expectations. The need for comprehensive testing methods has led to the adoption of advanced technologies in these sectors. North American companies and institutions invest heavily in research and development. This investment supports the creation and validation of cutting-edge dermal toxicity testing methods. The availability of resources and funding facilitates the growth and adoption of new technologies. The competitive nature of industries like cosmetics, pharmaceuticals, and chemicals in North America drives companies to adopt innovative approaches to stand out in the market. This includes the use of advanced dermal toxicity testing methods to ensure product safety and efficacy. North America has established collaborative networks between academic institutions, research organizations, and industry players. These networks facilitate knowledge sharing, research partnerships, and the development of standardized testing methods.

Recent Developments

  • In January 2021, Charles River Laboratories International Inc announced its collaboration with Cypre Inc. Cypre Inc is a prominent biotechnology company that uses 3D hydrogel technology. Under the collaboration, the company will be offering Charles River access to Falcon-X, Cypre’s 3D (patented) tumor model platform. The platform by Cypre aims to strengthen Charles River’s 3D in vitro testing services to boost approaches for immuno-oncological sector.
  • In August 2019, Intoximeters and Abbott announced that both companies have signed an agreement which permits intoximeters to market Abbott’s mobile testing system ‘SoToxa’. Abbott’s testing solutions is a handheld oral fluid roadside testing solution that offers a precise detection of drugs.
  • In October 2022, Thermo Fisher Scientific Inc. announced that it will expand its laboratory operations in Highland Heights, Kentucky, helping customers deliver life-changing medicines to patients. The current facility, which includes central lab and biomarker operations, provides biopharma customers with high-quality laboratory services to accelerate drug development. This helped the company to expand its clinical diagnostics business across various regions in the world and helped to increase its global presence in the market.

Key Market Players

  • SGS S.A..
  • Covance, Inc
  • Bio-Rad Laboratories Inc.
  • Qiagen N.V.
  • GE Healthcare
  • Eurofins Scientific Inc
  • Merck KgaA
  • Thermo Fisher Scientific, Inc.
  • Charles River Laboratories International, Inc.
  • Catalent, Inc.  

 By Test Type

By Testing Method Type

By End User

By Region
  • Skin Irritation Tests
  • Skin Sensitization Tests
  • In Vivo Testing (Animal-Based Tests)
  • In Vitro Testing (Cell-Based or Tissue-Based Tests  
  • Pharmaceuticals industries
  • Cosmetics and personal care products industry
  • Chemical Industry
  • Other  
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

 

Report Scope:

In this report, the Global Dermal Toxicity Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Dermal Toxicity Testing Market, By Test Type:

o   Skin Irritation Tests

o   Skin Sensitization Tests

  • Dermal Toxicity Testing Market, By Testing Method Type:

o   In Vivo Testing (Animal-Based Tests)

o   In Vitro Testing (Cell-Based or Tissue-Based Tests)

  • Dermal Toxicity Testing Market, By End User:

o   Pharmaceuticals industries

o   Cosmetics and personal care products industry

o   Chemical Industry

o   Other

  • Dermal Toxicity Testing Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Kuwait

§  Turkey

§  Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dermal Toxicity Testing Market.

Available Customizations:

Global Dermal Toxicity Testing market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Dermal Toxicity Testing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Dermal Toxicity Testing Market Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Test Type (Skin Irritation Tests, Skin Sensitization Tests)

5.2.2.    By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)

5.2.3.    By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)

5.2.4.    By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)

5.2.5.    By Company (2022)

5.3.  Market Map

5.3.1 By Test Type

5.3.2 By Testing Method Type

5.3.3 By End User

5.3.4 By Region

6.    North America Dermal Toxicity Testing Market Outlook

6.1.  Market Size & Forecast

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Test Type (Skin Irritation Tests, Skin Sensitization Tests)

6.2.2.    By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)

6.2.3.    By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)

6.2.4.    By Country

6.3.  North America: Country Analysis

6.3.1.    United States Dermal Toxicity Testing Market Outlook

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.            By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.            By Test Type

6.3.1.2.2.            By Testing Method Type

6.3.1.2.3.            By End User

6.3.2.    Canada Dermal Toxicity Testing Market Outlook

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.            By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.            By Test Type

6.3.2.2.2.            By Testing Method Type

6.3.2.2.3.            By End User

6.3.3.    Mexico Dermal Toxicity Testing Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.            By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.            By Test Type

6.3.3.2.2.            By Testing Method Type

6.3.3.2.3.            By End User

7.    Europe Dermal Toxicity Testing Market Outlook

7.1.  Market Size & Forecast

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Test Type (Skin Irritation Tests, Skin Sensitization Tests)

7.2.2.    By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)

7.2.3.    By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)

7.2.4.    By Country

7.3.  Europe: Country Analysis

7.3.1.    France Dermal Toxicity Testing Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.            By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.            By Test Type

7.3.1.2.2.            By Testing Method Type

7.3.1.2.3.            By End User

7.3.2.    Germany Dermal Toxicity Testing Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.            By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.            By Test Type

7.3.2.2.2.            By Testing Method Type

7.3.2.2.3.            By End User

7.3.3.    United Kingdom Dermal Toxicity Testing Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.            By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.            By Test Type

7.3.3.2.2.            By Testing Method Type

7.3.3.2.3.            By End User

7.3.4.    Italy Dermal Toxicity Testing Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.            By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.            By Test Type

7.3.4.2.2.            By Testing Method Type

7.3.4.2.3.            By End User

7.3.5.    Spain Dermal Toxicity Testing Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.            By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.            By Test Type

7.3.5.2.2.            By Testing Method Type

7.3.5.2.3.            By End User

8.    Asia-Pacific Dermal Toxicity Testing Market Outlook

8.1.  Market Size & Forecast

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Test Type (Skin Irritation Tests, Skin Sensitization Tests)

8.2.2.    By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)

8.2.3.    By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)

8.2.4.    By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.    China Dermal Toxicity Testing Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.            By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.            By Test Type

8.3.1.2.2.            By Testing Method Type

8.3.1.2.3.            By End User

8.3.2.    India Dermal Toxicity Testing Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.            By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.            By Test Type

8.3.2.2.2.            By Testing Method Type

8.3.2.2.3.            By End User

8.3.3.    Japan Dermal Toxicity Testing Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.            By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.            By Test Type

8.3.3.2.2.            By Testing Method Type

8.3.3.2.3.            By End User

8.3.4.    South Korea Dermal Toxicity Testing Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.            By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.            By Test Type

8.3.4.2.2.            By Testing Method Type

8.3.4.2.3.            By End User

8.3.5.    Australia Dermal Toxicity Testing Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.            By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.            By Test Type

8.3.5.2.2.            By Testing Method Type

8.3.5.2.3.            By End User

9.    South America Dermal Toxicity Testing Market Outlook

9.1.  Market Size & Forecast

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Test Type (Skin Irritation Tests, Skin Sensitization Tests)

9.2.2.    By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)

9.2.3.    By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)

9.2.4.    By Country

9.3.  South America: Country Analysis

9.3.1.    Brazil Dermal Toxicity Testing Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.            By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.            By Test Type

9.3.1.2.2.            By Testing Method Type

9.3.1.2.3.            By End User

9.3.2.    Argentina Dermal Toxicity Testing Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.            By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.            By Product

9.3.2.2.2.            By Test Type

9.3.2.2.3.            By Testing Method Type

9.3.2.2.4.            By End User

9.3.3.    Colombia Dermal Toxicity Testing Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.            By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.            By Test Type

9.3.3.2.2.            By Testing Method Type

9.3.3.2.3.            By End User

10.  Middle East and Africa Dermal Toxicity Testing Market Outlook

10.1.   Market Size & Forecast         

10.1.1. By Value

10.2.   Market Share & Forecast

10.2.1. By Test Type (Skin Irritation Tests, Skin Sensitization Tests)

10.2.2. By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)

10.2.3. By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry and Other)

10.2.4. By Country

10.3.   MEA: Country Analysis

10.3.1. South Africa Dermal Toxicity Testing Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Test Type

10.3.1.2.2.         By Testing Method Type

10.3.1.2.3.         By End User

10.3.2. Saudi Arabia Dermal Toxicity Testing Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Test Type

10.3.2.2.2.         By Testing Method Type

10.3.2.2.3.         By End User

10.3.3. UAE Dermal Toxicity Testing Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Test Type

10.3.3.2.2.         By Testing Method Type

10.3.3.2.3.         By End User

11.  Market Dynamics

11.1.   Drivers

11.2.   Challenges

12.  Market Trends & Developments

12.1.   Recent Development

12.2.   Mergers & Acquisitions

12.3.   Product Launches

13.  Global Dermal Toxicity Testing Market: SWOT Analysis

14.  Porter’s Five Forces Analysis

14.1.   Competition in the Industry

14.2.   Potential of New Entrants

14.3.   Power of Suppliers

14.4.   Power of Customers

14.5.   Threat of Substitute Products

15.  Competitive Landscape

15.1.   Business Overview

15.2.   Product Offerings

15.3.   Recent Developments

15.4.   Financials (As Reported)

15.5.   Key Personnel

15.6.   SWOT Analysis

15.6.1    SGS S.A..

15.6.2    Covance, Inc

15.6.3    Bio-Rad Laboratories Inc.

15.6.4    Qiagen N.V.

15.6.5    GE Healthcare

15.6.6    Eurofins Scientific Inc

15.6.7    Merck KgaA

15.6.8    Thermo Fisher Scientific, Inc.

15.6.9    Charles River Laboratories International, Inc.

15.6.10  Catalent, Inc.  

Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

The market size of the Global Dermal Toxicity Testing Market was estimated to be USD 1.81 Billion in 2022.

down-arrow

The Cosmetics and personal care products industry segment demonstrated significant dominance in 2022, due to Dermal toxicity testing offering an avenue for product differentiation. Brands that can demonstrate their commitment to safety through comprehensive testing can stand out in a crowded market.

down-arrow

North America emerged as the dominant market in 2022, capturing a significant revenue share. The competitive nature of industries like cosmetics, pharmaceuticals, and chemicals in North America drives companies to adopt innovative approaches to stand out in the market. This includes the use of advanced dermal toxicity testing methods to ensure product safety and efficacy.

down-arrow

Growing adoption of quality check products to prevent product recalls and rising emphasis on consumer product and medicine safety as well as the requirement to screen prospective therapeutic targets in the early stages of drug development are the major drivers for the Global Dermal Toxicity Testing Market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Dermal Toxicity Testing Market to Grow with a CAGR of 8.17% through 2028

Oct, 2023

Rising emphasis on consumer product and medicine safety as well as the requirement to screen prospective therapeutic targets in the early stages of drug development are expected to drive the Global D

Why Choose Us